{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Foreign", "lead_paragraph": "The grants aim to test the idea that diseases such as trachoma and hookworm, which largely afflict the rural poor, can be tackled together more effectively than one at a time.", "headline": {"main": "Gateses Give $47 Million to Bolster Coordinated Assaults on Diseases", "print_headline": "Gateses Give $47 Million to Bolster Coordinated Assaults on Diseases"}, "abstract": null, "print_page": "5", "word_count": "420", "_id": "54a97f6879881040cba0eb44", "snippet": "The grants aim to test the idea that diseases such as trachoma and hookworm, which largely afflict the rural poor, can be tackled together more effectively than one at a time.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2006/12/20/health/20diseases.html", "multimedia": [], "subsection_name": null, "keywords": [{"value": "Medicine and Health", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Gates, Bill and Melinda, Foundation", "is_major": "N", "rank": "2", "name": "organizations"}, {"value": "Africa", "is_major": "N", "rank": "3", "name": "glocations"}], "byline": {"person": [{"firstname": "Celia", "middlename": "W.", "lastname": "DUGGER", "rank": 1, "role": "reported", "organization": ""}], "original": "By CELIA W. DUGGER"}, "document_type": "article", "pub_date": "2006-12-20T00:00:00Z", "section_name": "Health"}, {"type_of_material": "Letter", "blog": [], "news_desk": "Letters", "lead_paragraph": "To the Editor:.", "headline": {"main": "Eli Lilly and the Dangers of a Drug (5 Letters)", "print_headline": "Eli Lilly and the Dangers of a Drug"}, "abstract": null, "print_page": "28", "word_count": "818", "_id": "54a97d6079881040cba0eb10", "snippet": "To the Editor:.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2006/12/20/opinion/l20drug.html", "multimedia": [], "subsection_name": null, "keywords": [{"value": "Medicine and Health", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Lilly, Eli, & Co", "is_major": "N", "rank": "2", "name": "organizations"}, {"value": "Food and Drug Administration", "is_major": "N", "rank": "3", "name": "organizations"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Liability For Products", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "Health Insurance and Managed Care", "is_major": "N", "rank": "6", "name": "subject"}], "byline": null, "document_type": "article", "pub_date": "2006-12-20T00:00:00Z", "section_name": "Opinion"}, {"type_of_material": "News", "blog": [], "news_desk": "Foreign Desk", "lead_paragraph": "The Bill & Melinda Gates Foundation is giving $47 million in grants for the control of neglected tropical diseases, now almost forgotten in wealthy nations, that still cause excruciating pain, disfigurement and disability for millions of the world's poorest people, the recipients announced yesterday. The grants are unusual in that they do not single out individual diseases. Instead, they aim to test the idea that diseases such as trachoma, river blindness, lymphatic filariasis and hookworm, which largely afflict the rural poor, can be tackled together more effectively and cheaply than one at a time.", "headline": {"main": "Gateses Give $47 Million to Bolster Coordinated Assaults on Diseases"}, "abstract": "Bill and Mellinda Gates Foundation donates $47 million for control of neglected tropical diseases that cause pain, disfigurement and disability among millions of world's poorest people; Dr Regina Rabinovich explains effort to shift away from appeals for high-profile diseases and encourage efficiencies of treatment for scourges such as river blindness, trachoma and lymphatic filariasis (M)", "print_page": "5", "word_count": 420, "_id": "4fd257cf8eb7c8105d802dfe", "snippet": "The Bill & Melinda Gates Foundation is giving $47 million in grants for the control of neglected tropical diseases, now almost forgotten in wealthy nations, that still cause excruciating pain, disfigurement and disability for millions of the world's...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/fullpage.html?res=9C0CE7DE1031F933A15751C1A9609C8B63", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "RABINOVICH, REGINA"}, {"name": "glocations", "value": "AFRICA"}, {"name": "organizations", "value": "GATES, BILL AND MELINDA, FOUNDATION"}, {"name": "subject", "value": "PHILANTHROPY"}, {"name": "subject", "value": "RIVER BLINDNESS"}, {"name": "subject", "value": "LYMPHATIC FILARIASIS"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "TRACHOMA"}, {"name": "subject", "value": "THIRD WORLD AND DEVELOPING COUNTRIES"}], "byline": {"person": [{"firstname": "Celia", "middlename": "W.", "lastname": "DUGGER", "rank": 1, "role": "reported", "organization": ""}], "original": "By CELIA W. DUGGER"}, "document_type": "article", "pub_date": "2006-12-20T00:00:00Z", "section_name": "World; Health"}, {"type_of_material": "Letter", "blog": [], "news_desk": "Editorial Desk", "lead_paragraph": "To the Editor: ''Eli Lilly Said to Play Down Risk of Top Pill'' (front page, Dec. 17), about the company's decision to cover up health effects of its top-selling schizophrenia medication, Zyprexa, is a good example of the strong link between product safety and product liability. Lawsuits are often the only means for the public to learn about dangerous drugs. This is especially true today, as the Food and Drug Administration has proved unable to keep some unsafe drugs off the market.", "headline": {"main": "Eli Lilly and the Dangers of a Drug"}, "abstract": "Five letters comment on Eli Lilly's marketing of schizophrenia medication Zyprexa (Dec 17 article and Dec 19 editorial); Joanne Doroshow, executive director, Center for Justice and Democracy, says that if lawsuits had not been brought, dangers of drug would not be known to wider public; Dr Marshal Mandelkern says Eli Lilly behaved as any for-profit corporation would and physicians must remain objective about drugs and not be financially entangled with drug or insurance companies; Pamela Spiro Wagner says Zyprexa was miracle antipsychotic for her; Barbara Fischkin says spector of autistic children using Zyprexa and gaining weight or developing diabetes is horrifying; David Berman says we need to get money-changers out of medicine and make drugs for people not for profit; drawing", "print_page": "28", "word_count": 813, "_id": "4fd272678eb7c8105d82f291", "snippet": "To the Editor:     ''Eli Lilly Said to Play Down Risk of Top Pill'' (front page, Dec. 17), about the company's decision to cover up health effects of its top-selling schizophrenia medication, Zyprexa, is a good example of the strong link between...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/fullpage.html?res=9F0CE6DD1031F933A15751C1A9609C8B63", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "BERMAN, DAVID"}, {"name": "persons", "value": "DOROSHOW, JOANNE"}, {"name": "persons", "value": "MANDELKERN, MARSHAL"}, {"name": "persons", "value": "WAGNER, PAMELA SPIRO"}, {"name": "persons", "value": "FISCHKIN, BARBARA"}, {"name": "organizations", "value": "LILLY, ELI, & CO"}, {"name": "subject", "value": "AUTISM"}, {"name": "subject", "value": "SCHIZOPHRENIA"}, {"name": "subject", "value": "CHILDREN AND YOUTH"}, {"name": "subject", "value": "ZYPREXA (DRUG)"}, {"name": "subject", "value": "MENTAL HEALTH AND DISORDERS"}], "byline": null, "document_type": "article", "pub_date": "2006-12-20T00:00:00Z", "section_name": "Opinion"}, {"type_of_material": "News", "blog": [], "news_desk": "Metro", "lead_paragraph": "The roughly $40 million that was set aside to treat workers who became ill after helping with the 9/11 cleanup and recovery will run out in months.", "headline": {"main": "Money to Treat 9/11 Workers Will Run Out, Officials Say", "print_headline": "Money to Treat 9/11 Workers Will Run Out, Officials Say"}, "abstract": null, "print_page": "1", "word_count": "937", "_id": "54a9790979881040cba0ea96", "snippet": "The roughly $40 million that was set aside to treat workers who became ill after helping with the 9/11 cleanup and recovery will run out in months.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2006/12/19/nyregion/19health.html", "multimedia": [{"subtype": "wide", "url": "images/2006/12/19/nyregion/190-x-126_1219-met-webHEALT.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2006/12/19/nyregion/190-x-126_1219-met-webHEALT.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2006/12/19/nyregion/600_health.jpg", "height": 300, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2006/12/19/nyregion/600_health.jpg", "xlargeheight": "300"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2006/12/19/nyregion/75_health.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2006/12/19/nyregion/75_health.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "World Trade Center (NYC)", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Fires and Firefighters", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "New York State", "is_major": "N", "rank": "4", "name": "glocations"}, {"value": "New Jersey", "is_major": "N", "rank": "5", "name": "glocations"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Sewell", "lastname": "CHAN"}], "original": "By SEWELL CHAN"}, "document_type": "article", "pub_date": "2006-12-19T00:00:00Z", "section_name": "N.Y. / Region"}, {"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "The warning was issued after two patients taking the cancer drug Rituxan as a treatment for the autoimmune disorder lupus died from a rare brain infection.", "headline": {"main": "Warning Given on Drug\u2019s Use to Treat Lupus", "print_headline": "Warning Given On Drug\u2019s Use To Treat Lupus"}, "abstract": null, "print_page": "2", "word_count": "336", "_id": "54a9778479881040cba0ea6c", "snippet": "The warning was issued after two patients taking the cancer drug Rituxan as a treatment for the autoimmune disorder lupus died from a rare brain infection.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2006/12/19/health/19lupus.html", "multimedia": [], "subsection_name": null, "keywords": [{"value": "Lupus (Disease)", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Biogen Idec Incorporated", "is_major": "N", "rank": "3", "name": "organizations"}, {"value": "Genentech Inc", "is_major": "N", "rank": "4", "name": "organizations"}, {"value": "Medicine and Health", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "Cancer", "is_major": "N", "rank": "6", "name": "subject"}, {"value": "Multiple Sclerosis", "is_major": "N", "rank": "7", "name": "subject"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Bloomberg", "lastname": "NEWS"}], "original": "By BLOOMBERG NEWS"}, "document_type": "article", "pub_date": "2006-12-19T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "Biogen Idec and Genentech have warned doctors of two deaths among patients receiving the cancer drug Rituxan as a treatment for the autoimmune disorder lupus. The medicine, used to treat patients with non-Hodgkin's lymphoma and rheumatoid arthritis, is not approved as a therapy for lupus, Biogen, based in Cambridge, Mass., said yesterday in a regulatory filing. The patients developed a rare brain infection called progressive multifocal leukoencephalopathy, or P.M.L., the companies said.", "headline": {"main": "Warning Given On Drug's Use To Treat Lupus"}, "abstract": "Biogen Idec and Genentech warn doctors o", "print_page": "2", "word_count": 336, "_id": "4fd279c48eb7c8105d83d179", "snippet": "Biogen Idec and Genentech have warned doctors of two deaths among patients receiving the cancer drug Rituxan as a treatment for the autoimmune disorder lupus.     The medicine, used to treat patients with non-Hodgkin's lymphoma and rheumatoid...", "source": "Bloomberg News", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/fullpage.html?res=9B0CE5D81331F93AA25751C1A9609C8B63", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "GENENTECH INC"}, {"name": "organizations", "value": "BIOGEN IDEC INC"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "LUPUS"}, {"name": "subject", "value": "RITUXAN (DRUG)"}], "byline": null, "document_type": "article", "pub_date": "2006-12-19T00:00:00Z", "section_name": "Health; Business"}, {"type_of_material": "News", "blog": [], "news_desk": "Metropolitan Desk", "lead_paragraph": "Gov. Jon S. Corzine announced yesterday that New Jersey would offer $7 million worth of grants for embryonic stem cell research, and $3 million for the less controversial area of adult stem-cell research. The grants, which double the amount given during last year's first-ever round of grants, are intended to augment the state's attempt to become one of the leading laboratories for such research, which supporters hope can eventually help find cures for diseases like Parkinson's, pediatric AIDS and sickle cell anemia. DAVID W. CHEN", "headline": {"main": "Metro Briefing | New Jersey: Trenton: Stem Cell Research Grants"}, "abstract": "New Jersey to offer $7 million in grants for embryonic stem cell research and $3 million for less controversial area of adult stem-cell research; grants are double those awarded in 2005 (S)", "print_page": "6", "word_count": 85, "_id": "4fd272678eb7c8105d82f27e", "snippet": "Gov. Jon S. Corzine announced yesterday that New Jersey would offer $7 million worth of grants for embryonic stem cell research, and $3 million for the less controversial area of adult stem-cell research. The grants, which double the amount given...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/fullpage.html?res=9B07E3D61331F93AA25751C1A9609C8B63", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "NEW JERSEY"}, {"name": "subject", "value": "FETAL TISSUE"}, {"name": "subject", "value": "EMBRYOLOGY (FETOLOGY)"}, {"name": "subject", "value": "FINANCES"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "RESEARCH"}, {"name": "subject", "value": "BUDGETS AND BUDGETING"}], "byline": {"person": [{"firstname": "David", "middlename": "W.", "lastname": "CHEN", "rank": 1, "role": "reported", "organization": ""}], "original": "By DAVID W. CHEN; Compiled by Thomas J. Lueck"}, "document_type": "article", "pub_date": "2006-12-19T00:00:00Z", "section_name": "Health; New York and Region"}, {"type_of_material": "Editorial", "blog": [], "news_desk": "Editorial", "lead_paragraph": "A new study shows that the battles against AIDS and malaria are really one fight.", "headline": {"main": "The AIDS-Malaria Connection", "print_headline": "The AIDS-Malaria Connection", "content_kicker": "Editorial"}, "abstract": null, "print_page": "28", "word_count": "359", "_id": "54a971d679881040cba0e9ca", "snippet": "A new study shows that the battles against AIDS and malaria are really one fight.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2006/12/18/opinion/18mon2.html", "multimedia": [], "subsection_name": null, "keywords": [{"value": "Acquired Immune Deficiency Syndrome", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Malaria", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Viruses", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Africa", "is_major": "N", "rank": "5", "name": "glocations"}, {"value": "Kenya", "is_major": "N", "rank": "6", "name": "glocations"}], "byline": null, "document_type": "article", "pub_date": "2006-12-18T00:00:00Z", "section_name": "Opinion"}, {"type_of_material": "News", "blog": [], "news_desk": "Magazine", "lead_paragraph": "A philosopher\u2019s case for donating more than you\u2019re comfortable with.", "headline": {"main": "What Should a Billionaire Give \u2013 and What Should You?", "print_headline": "What Should a Billionaire Give \u2013 and What Should You?"}, "abstract": null, "print_page": null, "word_count": "6072", "_id": "546824b779881054c64b0b49", "snippet": "A philosopher\u2019s case for donating more than you\u2019re comfortable with.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2006/12/17/magazine/17charity.t.html", "multimedia": [{"subtype": "xlarge", "url": "images/2006/12/13/magazine/17donation.600.jpg", "height": 280, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2006/12/13/magazine/17donation.600.jpg", "xlargeheight": "280"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2006/12/13/magazine/17donation.75.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2006/12/13/magazine/17donation.75.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Philanthropy", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Sociology", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Ethics", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Politics and Government", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "Gates, Bill", "is_major": "N", "rank": "6", "name": "persons"}, {"value": "Buffett, Warren E", "is_major": "N", "rank": "7", "name": "persons"}, {"value": "Gates, Melinda", "is_major": "N", "rank": "8", "name": "persons"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Peter", "lastname": "SINGER"}], "original": "By PETER SINGER"}, "document_type": "article", "pub_date": "2006-12-17T00:00:00Z", "section_name": "Magazine"}], "meta": {"hits": 14, "offset": 0, "time": 31}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}